A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 162 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Creating innovative medicines and new horizons in healthcare
7 June 2019

A couple of hundred years ago, pneumonia and appendicitis were a fatal diagnosis and surgeons had no idea about the need to wash their hands before surgery. Medicine is moving forward alongside technological progress. Infectious disease epidemics are becoming a thing of the past, giving way to new, previously unknown diseases, for which neither treatment nor their consequences are yet fully understood. Today, advanced technologies not only allow for unique surgeries and diseases prevention, but also new treatments. One of the goals of the National Medicines Policy 2030 is to develop domestic innovative medicines. The development of a new medicine — from the idea to implementation — takes more than ten years and requires huge investments with high risks. Biomedical cell products (BMCP) have become a new driver for the global medicine market. Russia has already undertaken vast research and development in this field that might allow it to overtake the U.S. and the EU in terms of BMCP output over the next few decades. What are Russia’s priorities for developing new medicines? Which agency should manage the programme for the development of innovative medicines? What measures of state support and stimulus of commercialization are needed for the BMCP industry and the creation of innovative medicines? How attractive are investments in biomedical cell technologies? Will cell products become the ‘magic pill’ to combat 21st century diseases?

Started at
Conference hall
Pavilion G, conference hall G7
Analytics on the topic